Status:
WITHDRAWN
Role of Repeat Resection in Recurrent Glioblastoma
Lead Sponsor:
University of Alberta
Conditions:
Recurrent Glioblastoma
Glioblastoma - Category
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with recurrent Glioblastoma (GBM) are commonly presented to surgeons, along with the question of whether or not to re-resect the recurrence. There is no Level 1 evidence to support a role for...
Detailed Description
Glioblastoma (GBM) is the most common malignant brain tumor (48.3% of malignant tumors).1 It has a predilection for Caucasian men with a mean age of 65.1, 2 There are approximately 13,000 new diagnose...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Previously histologically confirmed and surgically resected Glioblastoma
- Previous craniotomy for open tumor resection (needle biopsies alone do not count as resection)
- The attending surgeon considers re-operation may improve quality survival
Exclusion
- Informed consent not possible
Key Trial Info
Start Date :
August 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04838782
Start Date
August 26 2021
End Date
March 24 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Division of Neurosurgery
Edmonton, Alberta, Canada, T6G 2B7